Australia markets close in 30 minutes
  • ALL ORDS

    7,396.60
    +71.40 (+0.97%)
     
  • ASX 200

    7,149.50
    +68.70 (+0.97%)
     
  • AUD/USD

    0.7856
    +0.0008 (+0.10%)
     
  • OIL

    65.17
    +0.27 (+0.42%)
     
  • GOLD

    1,836.00
    +4.70 (+0.26%)
     
  • BTC-AUD

    74,895.62
    +128.13 (+0.17%)
     
  • CMC Crypto 200

    1,560.50
    +124.72 (+8.69%)
     
  • AUD/EUR

    0.6460
    +0.0013 (+0.19%)
     
  • AUD/NZD

    1.0787
    +0.0014 (+0.13%)
     
  • NZX 50

    12,659.01
    -70.91 (-0.56%)
     
  • NASDAQ

    13,719.63
    +105.93 (+0.78%)
     
  • FTSE

    7,129.71
    +53.54 (+0.76%)
     
  • Dow Jones

    34,777.76
    +229.26 (+0.66%)
     
  • DAX

    15,399.65
    +202.95 (+1.34%)
     
  • Hang Seng

    28,465.92
    -144.73 (-0.51%)
     
  • NIKKEI 225

    29,516.95
    +159.13 (+0.54%)
     

Plasma Fractionation Market Size is Expected to Reach $23.00 Billion by 2027: Says AMR

Allied Market Research
·5-min read

Increase in geriatric population across the world, surge in the incidence of rare diseases, rise in use of immunoglobulins in medicine, and emergence of plasma collection centers in different countries fuel the growth of the global plasma fractionation market. On the basis of sector, the private sector held the major share in 2019. Based on region, on the other hand, North America held the major share in 2019.

Portland, OR, April 21, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Plasma Fractionation Market was estimated at $18.22 billion in 2019 and is expected to hit $23.00 billion by 2027, registering a CAGR of 6.2% from 2020 to 2027. The report provides an all-inclusive analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/943

Increase in geriatric population across the world, surge in the incidence of rare diseases, rise in use of immunoglobulins in medicine, and emergence of plasma collection centers in different countries fuel the growth of the global plasma fractionation market. On the other hand, high cost of plasma derived products impedes the growth to some extent. Nevertheless, high growth potential in emerging economies is expected to pave the way for lucrative opportunities for the frontrunners in the industry.

Covid-19 scenario-

  • The outbreak of covid-19 led to postponements of planned surgeries across the world. Cases of hospital admission were also declined substantially. This factor affected the global plasma fractionation market.

  • Simultaneously, the pandemic has also given way to a steep decline in the count of blood donations and plasma collections.

The global plasma fractionation market is analyzed across product, sector, and region. On the basis of product, the immunoglobulin segment contributed to around two-thirds of the total market share in 2019 and is anticipated to dominate by 2027. The albumin segment, on the other hand, would register the fastest CAGR of 6.3% during the forecast period.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/943

On the basis of sector, the private sector accounted for more than three-fifths of the total market revenue in 2019 and is projected to retain its dominance throughout the forecast period. The same sector would also cite the fastest CAGR of 6.4% by the end of 2027.

Based on region, North America generated the major share in 2019, garnering around half of the global plasma fractionation market. Simultaneously, the region across Asia-Pacific would exhibit the fastest CAGR of 6.6% from 2020 to 2027. The other two provinces covered in the report include Europe and LAMEA.

The key market players analyzed in the global plasma fractionation market report include Bio product laboratory, Biotest AG, Takeda Pharmaceutical Company Limited, CSL Ltd., Grifols SA, Kedrion S.P.A (Kedrion Biopharma Inc.), LFB S. A., Octapharma AG, Baxter International Inc., and Sanquin Blood Supply Foundation. These market players have taken recourse to several strategies including partnership, expansion, collaboration, joint ventures, and others to prove their bent in the industry.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Similar Reports:

Immunoglobulin Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

Blood Plasma Derivatives Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Cold Plasma Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Albumin Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Enzyme Replacement Therapy Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Holographic Imaging Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Immunoassay Interference Blocker Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research